Fund Research for GMO Intl Intrinsic Value III (GMOIX)

  • Fund Overview

    Fund Inception Date: Mar 31, 1987
    Category: Foreign Large Value
    Overall Risk: Below Average
    Fund Family: GMO
    Return Since Inception: 8.42%
    YTD Return: 17.78%
    Yield (TTM): 3.83%
    Net Assets: 2.06 B
    Morningstar Rating:
    4 of 5

    The investment seeks high total return. The fund primarily invests in common stocks of non-U.S. issuers, including dividend-paying common stocks. It maintains investments in no fewer than three foreign countries. The relative emphasis on capital appreciation or income depends on the views of management. To determine geographic allocation, management evaluates the growth potential of different markets, currency and taxation considerations, and other pertinent social, financial, political, and national factors. The fund may also enter into various derivative transactions for hedging and risk-management purposes.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player
    Size
    Average Market Cap $21,594 M
    Market Capitalization Portfolio
    Giant 53.21%
    Large 28.10%
    Medium 17.52%
    Small 1.16%
    Micro 0.01%
    Morningstar Rating as of 10/31/2009
    YTD Returns as of 11/27/2009    		 Style Box Detail calculations do not include the fund's short positions (if any)

  • Fund Performance

    10 year Growth Chart
    Growth of $10,000 from 12/31/1998 to 10/31/2009
    Mouseover the chart to see values for each month.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player

    Total Annualized Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Fund 17.78% 27.86% -5.82% 3.56% 5.97% 8.42%
    +/- Category -10.75% -10.99% -0.72% -0.01% 1.80% —
    +/- MSCI EAFE NR USD — — — — 2.04% —

    Standardized Annual Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Month (as of 10/31/2009) 15.57% 17.85% -6.42% 4.32% 5.97% 8.42%
    Quarter (as of 09/30/2009) 19.42% -1.19% -4.34% 5.66% 6.33% 8.61%
    Fund and Category YTD, 1yr, 3yr and 5yr Returns as of 11/27/2009
    Index YTD,1yr, 3ys and 5yr Returns as of 11/27/2009 10 yr and Since Inception Returns as of 10/31/2009
    Inception Date: 03/31/1987
    Ratings are based on risk-adjusted performance.
    View Total Returns

  • Fund Portfolio Profile

    Sector Breakdown

    Stocks
    Information 9.88%
    Service 47.19%
    Manufacturing 37.88%

    Asset Allocation

    Short Long Net Assets
    Cash 8.71% 11.27% 2.56%
    Stocks 0.00% 97.33% 97.33%
    Bonds 0.00% 0.00% 0.00%
    Other 0.00% 0.00% 0.00%
    Foreign Stocks
    (as a % of assets)    		 0.00% 97.33% 97.33%
    Data as of 08/31/2009 Data as of 08/31/2009 View Fund Portfolio

    Top 10 Holdings

    Sector Country Net Assets
    + GlaxoSmithKline PLC (GLAXF) Healthcare GBR 3.91%
    + Sanofi-Aventis (SAN) Healthcare FRA 3.13%
    - Novartis Healthcare CHE 2.74%
    * Bbh Other Net Asset — — 2.43%
    + ASTRAZENECA ORD SHS $0.25 (AZN) Healthcare GBR 2.32%
    * DAX Index (Fut) — — 2.26%
    - Total SA (FP) Energy FRA 1.86%
    - Nestle (NESN) Consumer Goods CHE 1.84%
    - Eni (ENI) Energy ITA 1.77%
    * F/C Cac40 10 Euro Fut Jun09 — — 1.61%
    + Increase - Decrease = No change * New since last portfolio
    Top 10 holdings account for the fund's short positions (if any). Net short positions appear shaded.
    Data as of 05/31/2009
    View Fund Portfolio

  • Sales Information

    Sales Charge %

    Initial —
    Deferred —
    Taken from prospectus dated 09/24/2009
    Expense Ratio (based on net assets) 0.67%
    Taken from annual report dated 02/28/2009

  • Fund Management